Tomas Vilimas

1.5k citations
8 papers · 829 indexed · h-index 8
Topics
T-cell and Retrovirus Studies (2 papers)Immune Cell Function and Interaction (2 papers)Pancreatic and Hepatic Oncology Research (1 paper)
Partner nations
United StatesItalyCanada

In The Last Decade

Tomas Vilimas

8 papers receiving 819 citations

Peers

Tomas Vilimas
Comparison fields: 5 of 50
  • Molecular Biology 572
  • Oncology 202
  • Immunology 202
  • Public Health, Environmental and Occupational Health 193
  • Hematology 167
Replace Archana Agarwal with:
Archana Agarwal United States
Mark Y. Chiang United States
Tetsuharu Shinjyo Japan
Daniel Fitzsimmons United States
Carol Wai Canada
Takuo Katsumoto Japan
Elizabeth J. Heller United States
Eva Welinder Sweden
Manuela Capillo Italy
Todd Ashworth United States
Tomas Vilimas relative to Archana Agarwal United States Archana Agarwal's profile →
Citations per field
00.5×1.5×2.0×
Archana Agarwal · 1×
Citations per year

Countries citing papers authored by Tomas Vilimas

Since Specialization
Citations

This map shows the geographic impact of Tomas Vilimas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Vilimas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Vilimas more than expected).

Fields of papers citing papers by Tomas Vilimas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Vilimas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Vilimas. The network helps show where Tomas Vilimas may publish in the future.

Co-authorship network of co-authors of Tomas Vilimas

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Vilimas. A scholar is included among the top collaborators of Tomas Vilimas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Vilimas. Tomas Vilimas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 7
2 42
3 13
4 363
5 83
6 43
7 261
8 17

About Tomas Vilimas

Tomas Vilimas is a scholar working on Aging, Immunology and Oncology, having authored 8 papers that have together received 829 indexed citations. Recurring topics across this work include T-cell and Retrovirus Studies (2 papers), Immune Cell Function and Interaction (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Hematology (167 citations), Aging (22 citations) and Immunology (202 citations). Tomas Vilimas has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Iannis Aifantis, Adolfo A. Ferrando, Silvia Buonamici, Teresa Palomero, Benjamin J. Thompson, Maria Luisa Sulis, Giuseppe Basso, Malay Mandal, Christina Spaulding and Barbara L. Kee. Their work appears in journals such as Nature Medicine, The Journal of Experimental Medicine and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026